Cognos Therapeutics Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Reverse Merger
  • (Upcoming)

  • Latest Deal Amount
  • $124M

Cognos Therapeutics General Information

Description

Cognos Therapeutics Holdings Inc is a medical technology company focused on creating advanced implantable pump devices for neurological and oncological indications. Its goal is to develop devices that adjust the course of therapeutics for the treatment and mitigation of disease models where current technology does not provide an effective solution. Its flagship product, the SINNAIS Implantable Smart Pump (SINNAIS), is the result of over a decade and a half of research and development in the field of implantable drug delivery pumps. SINNAIS represents a platform designed for the future, incorporating microelectronics, communication capabilities, and embedded programmable parameters in its architecture.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Drug Delivery
Corporate Office
  • 10604 South La Cienega Boulevard
  • Inglewood, CA 90304
  • United States
+1 (310) 000-0000

Cognos Therapeutics Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cognos Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Reverse Merger $124M Upcoming Generating Revenue
7. Seed Round 31-Mar-2022 00.00 Cancelled Generating Revenue
6. Angel (individual) 12-Oct-2021 000.00 00.00 Completed Generating Revenue
5. Angel (individual) 15-Jul-2021 00000 00.000 Completed Generating Revenue
4. Seed Round 21-May-2021 00.000 00.000 Completed Pre-Clinical Trials
3. Angel (individual) 29-May-2018 00000 00000 Completed Startup
2. Angel (individual) 20-Apr-2016 $48K $208K Completed Startup
1. Angel (individual) 07-Dec-2015 $160K $160K Completed Startup
To view Cognos Therapeutics’s complete valuation and funding history, request access »

Cognos Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Cognos Therapeutics Holdings Inc is a medical technology company focused on creating advanced implantable pump devices f
Therapeutic Devices
Inglewood, CA
8 As of 2022
00.00
0000000 0000

000000

it esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidata
00000000000 0000000
Minneapolis, MN
00000 As of 0000
000.00
000000000 00 000.00

000000

ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate ve
000000000000000
North Chicago, IL
000000 As of 0000
000.00
000000000 00 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cognos Therapeutics Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Medtronic Corporation Minneapolis, MN 00000 000.00 000000000 00 000.00
Abbott Corporation North Chicago, IL 000000 000.00 000000000 00 000.00
You’re viewing 2 of 2 competitors. Get the full list »

Cognos Therapeutics Patents

Cognos Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230191095-A1 Inline pressure and temperature sensor for cerebral shunts Pending 22-Dec-2021 0000000000
US-20220161076-A1 Method for extinguishing an electrochemical generator in the event of a thermal runaway Pending 15-May-2019 00000000
US-20200368428-A1 Hermetic seal for use in an implantable metronomic drug pump and a mehtod of manufacturing the same Pending 29-Apr-2019 0000000000
US-20200338325-A1 Method and apparatus for a long-term, fully implantable mri compatible drug pump Pending 29-Apr-2019 00000000000 0
EP-3746065-A1 Intratumoral delivery of bortezomib Pending 29-Jan-2018 A61K9/0085
To view Cognos Therapeutics’s complete patent history, request access »

Cognos Therapeutics Executive Team (11)

Name Title Board Seat Contact Info
Frank Adell Chief Executive Officer & Founder
Medi Abbis Interim Chief Financial Officer
Thomas Lobl Ph.D Chief of Research & Operation, Chief Operating Officer & Consultant
Winston Wu Chief Technology Officer, Technology & Senior Vice President
Thomas Chen Ph.D Board Member & Executive
You’re viewing 5 of 11 executive team members. Get the full list »

Cognos Therapeutics Board Members (19)

Name Representing Role Since
Andrew Sloan MD Self Board Member 000 0000
Eli Gang MD Cognos Therapeutics Chief Medical Officer and Board Member 000 0000
Frederick Lang Jr. Self Board Member 000 0000
Hani Gabra MD Self Chairman 000 0000
Jeffrey Bruce MD Self Board Member 000 0000
You’re viewing 5 of 19 board members. Get the full list »

Cognos Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cognos Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Nocturne Acquisition 03-Jan-2023 0000000000 Special Purpose Acquisition Company (SPAC)
To view Cognos Therapeutics’s complete acquisitions history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »